About: http://data.cimple.eu/news-article/fd9c514edd219b5cd10bb866aaa9ac8e55ced46b180338b64de605ef     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • Health Minister Jens Spahn said Friday that Germany would have to wait until "mid-to-late April" for the newly approved Johnson & Johnson coronavirus vaccine, adding that the EU is querying the company over the delays. Johnson & Johnson's single-dose Covid vaccine became the fourth jab to be authorised for use in the European Union Thursday, but Spahn warned that Germany would have to wait at least another month to receive the first doses from the US firm. "It's a pain with Johnson & Johnson. We have a European authorisation, but the deliveries will only be there from mid-to-late April at the earliest," said the minister at a weekly press conference in Berlin. He added that the European commission was in talks with the company over the problem. "We made an advance payment of 300 million euros for production and signed a contract in October, so we of course have to ask what has happened," he said. He said that Germany and the EU were now working on "short-term solutions" to the problem such as setting up production facilities in Germany. Yet he pointed the finger at vaccine producers, saying that short-term solutions wouldn't be needed if "they had organised things months ago when the contracts were signed." The EU has been struggling with a disappointing vaccination rollout that started in January and faltered because of a shortage of doses produced by the three suppliers so far. On Friday, Spahn said that while Germany expected to receive nine million doses from BionTech in April, other producers had been less reliable. "With AstraZeneca and Moderna, the planning periods and the question of whether there will be adjustments is a little more volatile, which has to do with production processes," he said. "It all depends on whether and to what extent producers are able to keep to their delivery commitments." Problems with supplies have contributed to a stuttering inoculation rollout that has left EU nations trailing behind the likes of the United States, Britain and Israel. The head of the EU's vaccine supply task force, Thierry Breton, said on Tuesday the EU's "bumpy" vaccine strategy should be augmented by the addition of the Johnson & Johnson jab, despite reports of production shortfalls in the US. "Do not believe that because one company has a problem that overall it will jeopardise the whole programme," he said. kih/hmn/lc
schema:headline
  • Germany expects J&J jabs only in April
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
Faceted Search & Find service v1.16.123 as of May 22 2025


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3241 as of May 22 2025, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 8 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2026 OpenLink Software